2018 BIO International Convention - Tagged with Interest Area

What Was Hot at ASCO’18?: Highlights from the World’s Biggest Oncology Meeting

11:00 AM–12:00 PM Jun 6, 2018

Dr. Laurie GlimcherPresident and Chief Executive Officer atDana-Farber Cancer Institute Dr. Jeffery KutokChief Scientific Officer atInfinity Pharmaceuticals, Inc. Dr. Thomas LynchExecutive Vice President, Chief Scientific Officer atBristol-Myers Squibb

Business Development & Finance

Using America’s Seed Fund (SBIR/STTR) and NIH Technology Transfer to Accelerate Technology Development and Secure Follow-On Investments

3:00 PM–4:00 PM Jun 6, 2018

Room 252AB, Level 2

Ms. Stephanie FertigDirector, NINDS Small Business Programs atNational Institutes of Health (NIH) Jonathan FlemingPresident/CEO/General Partner atQ-State Biosciences and Oxford Biosciences Partner Todd HaimProgram Director atNCI SBIR Kuldeep Neote, PhDSenior Director of New Ventures at the Johnson & Johnson Innovation atJohnson & Johnson Innovation Dr. Thomas NeumannPresident and CEO atNortis Inc Dr. Michael SalgallerSupervisor, Invention Development and Marketing Unit atNational Institutes of Health

Orphan & Rare Diseases

Newborn Screening: Ensuring All Babies Live Their Healthiest Lives

11:00 AM–12:00 PM Jun 6, 2018

Room 209, Level 2

Nicole BoiceCEO and Founder atGlobal Genes Paldeep Atwal, FRCP,MDGeneticist atGenome Medical Mr. Max BronsteinSenior Director, Health Policy & Corporate Affairs atAudentes Mark DantVolunteer Executive Director & Founder atRyan Foundation Richard WestCEO & Co-Founder atBaebies, Inc.

Orphan & Rare Diseases

Orphan & Rare Disease Track Opening Remarks and Session: Patient Value in HTA and Access Decisions

11:00 AM–12:15 PM Jun 5, 2018

Room 209, Level 2

Kathleen E. Hughes, MBAVice President atAvalere Health LLC Dennis JackmanSenior Vice President, Public Affairs atCSL Behring Mark Linthicum, MPPDirector of Scientific Communications atInnovation and Value Initiative Paul Melmeyer, MPPDirector of Federal Policy atNational Organization for Rare Disorders (NORD)

Brain Health

Tapping, Zapping, Hacking and Mapping the Nervous System through pioneering Bioelectronic Nerve Implants and Neural AI to Stop Chronic Disease

4:15 PM–5:15 PM Jun 6, 2018

Room 255, Level 2

Sanjeev WadhwaChief Executive Officer atLife Singularity, Inc. Chad BoutonDirector, The Center for Bioelectronic Medicine; VP, Advanced Engineering, Northwell Health atThe Feinstein Institute for Medical Research, NorthWell Health Dr. Ed Boyden, PhDY. Eva Tan Professor in Neurotechnology at MIT atMIT Media Lab and the MIT McGovern Institute Dr. Michel Maharbiz, PhDProfessor, Electrical Engineering and Computer Science atUniversity of California, Berkeley

Next Generation Biotherapeutics

Harnessing the Body's Regenerative Capabilities – Therapeutic Development from the Clinic to Commercialization

11:00 AM–12:00 PM Jun 5, 2018

Room 210B, Level 2

Morrie RuffinManaging Director atAlliance for Regenerative Medicine Mr. David LucchinoCEO atFrequency Therapeutics Felicia Pagliuca, PhDScientific Co-Founder, Vice President of Cell Biology Research and Development atSemma Therapeutics Antonio RegaladoSenior Editor atMIT Technology Review Michael ScottSenior Vice President, Product Development atBlueRock Therapeutics Dr. Steven SticeCo-Founder, Chief Scientific Officer atArunA Bio

What’s Next: The Landscape of Innovation in 2018 and Beyond

3:00 PM–4:15 PM Jun 4, 2018

Room 205ABC, Level 2

Sam UlinManaging Director atClearView Healthcare Partners Chris Von Seggern, MBA,MPH,PhDPartner atClearView Healthcare Partners

Delivering on the Promise of Gene Therapy

2:30 PM–3:45 PM Jun 5, 2018

Room 253ABC, Level 2

Steve BagshawChief Executive Officer atFUJIFILM Diosynth Biotechnologies Michael DombeckSenior Vice President, Corporate Development atPrecision BioSciences Alison FingerChief Commercial Officer atbluebird bio GmbH Sandy MacraeChief Executive Officer atSangamo Therapeutics John Pieracci, PhDDirector, Gene Therapy Process Development atBiogen Corporation Bob SmithSenior Vice President, Global Gene Therapy Business, Rare Disease atPfizer Inc.

Genome Editing

Engaging Our Nation and Our World in the Era of Gene Editing

9:00 AM–10:15 AM Jun 7, 2018

Room 210B, Level 2

Dr. Marnie GelbartDirector of Programs atPersonal Genetics Education Project (pgEd) Khalil Abdur-RashidMuslim Chaplain atHarvard University Rev. Nathan Barczi, PhDAssociate Pastor atChrist the King Presbyterian Church - Cambridge Michael FriendCo-Founder atMinority Coalition for Precision Medicine Fabienne MondesirDirector of Community Engagement atPersonal Genetics Education Project (pgEd)

Brain Health

Exposing Cracks in the Armor of Brain Diseases

9:00 AM–10:15 AM Jun 7, 2018

Room 255, Level 2

Mr. John Alam, ACHACEO atEIP Pharma Dr. Jeff Gulcher, MD,PhDCSO atWuXi NextCODE Christopher MisslingPresident & CEO atAnavex Life Sciences Corp. Aidan Power, BCH,MB,MRCP,MScVice President of Program and Portfolio Management atAlzheon Dr. George VlasukCEO atNavitor Pharmaceuticals

Genome Editing

Advances in Genome Editing – The Next Frontier in Human Health

1:45 PM–2:45 PM Jun 6, 2018

Room 210B, Level 2

Lakiea BaileyExecutive Director. WWBD atSickle Cell Community Consortium Ms. Katrine BosleyCEO atEditas Medicine Mike Certo, PhDHead, Genome Editing atbluebird bio GmbH Samarth KulkarniChief Executive Officer atCRISPR Therapeutics

Next Generation Biotherapeutics

Engineered Living Medicines: The Next Wave of Novel Therapeutics for Patients

4:00 PM–5:00 PM Jun 4, 2018

Room 210B, Level 2

Dr. James CollinsHenri Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering atMcGovern Institute for Brain Research at MIT Dr. Seth Ettenberg, PhDChief Scientific Offier atUnum Therapeutics Dr. Nerissa KreherChief Medical Officer atTiburio Dr. Bastiano SannaChief Executive Officer atSemma Therapetutics

Fireside Chat with Mikael Dolsten, MD, PhD, President, Worldwide Research and Development, Pfizer, Inc.

3:30 PM–4:30 PM Jun 6, 2018

Room 254AB, Level 2

Simone FishburnVice President atBiocentury and Biocentury Innovations Stephen WiviottExecutive Director, Clinical Trials Office atPartners Healthcare Mikael DolstenChief Scientific Officer and President, Worldwide Research, Development and Medical atPfizer, Inc.

Digital Health

Going Deep: How AI and Machine Learning will Transform Drug Discovery

1:45 PM–2:45 PM Jun 6, 2018

Room 210C, Level 2

Richard SollSenior Advisor, Strategic Initiatives atWuXi AppTec Dr. Atul Butte, MD,PhDPriscilla Chan and Mark Zuckerberg Distinguished Professor and Institute Director atUniversity of California, San Francisco Gini DeshpandeFounder & CEO atNuMedii Amit MehtaTechnology Innovation, Business Development atGenentech, A Member of the Roche Group Vijay PandeProfessor of Chemistry, Structural Biology and Computer Science, Stanford atStanford University & Andreessen Horowitz

Biofuels & Renewable Chemicals

Industrial Biotechnology Innovation is brewing protein!

1:45 PM–2:45 PM Jun 5, 2018

Room 255, Level 2

Vince SewaltSr. Dir., Product Stewardship & Regulatory atDuPont Industrial Biosciences Isha DatarExecutive Director atNew Harvest Eric SchulzeVP of Product and Regulation atMemphis Meats Mike SeldenCEO atFinless Foods

Digital Health

Navigating Uncharted Waters in Digital Medicine

4:15 PM–5:15 PM Jun 6, 2018

Room 210C, Level 2

Marisa CruzSenior Medical Advisor for Digital Health atFDA Mostafa KamalChief Executive Officer atSpeaker Eddie Martucci, PhDCEO atAkili Labs Dr. Corey McCann, MD,PhDCEO atPear Therapeutics Rebecca SpaldingBiotechnology Reporter atBloomberg L.P.

Scientific American WorldVIEW: Biotechnology’s Promise in a Changing Landscape

12:00 PM–1:30 PM Jun 7, 2018

Room 253ABC, Level 2

Lisa MeltonSenior News Editor atNature Biotechnology Hon. Jorge AguadoVice Minister atArgentina Kevin AliPresident, MSD International atMerck & Co, Inc. Kate BinghamManaging Director atSV Health Investors Kenneth Kaitin, PhDProfessor of Medicine and Director, Tufts Center for the Study of Drug Development atTUFTS UNIVERSITY SCHOOL OF MEDICINE Robert Urban, PhDGlobal Head atJ & J Innovation

Digital Health

The Confidence of Conviction: New Technologies and Digital Advances for Drug Discovery

10:30 AM–11:45 AM Jun 7, 2018

Room 210C, Level 2

Ms. Colleen CuffaroPrincipal atCanaan Partners Daniel Levner, MS,PhDChief Technology Officer atEmulate Inc. Dr. Russell Petter, PhDChief Scientific Officer atArrakis, Inc. Rachel ShaVice President, Digital Business Development & Licensing atSanofi

Brain Health

Whole Genomes and Autism: Bridging the Gap from Basic Research to Promising Autism Treatments

3:00 PM–4:00 PM Jun 6, 2018

Room 255, Level 2

Dr. Thomas Frazier, PhDChief Science Officer atAutism Speaks Dr. Mark GurneyChairman & CEO atTetra Discovery Partners, Inc. Dr. Mustafa Sahin, MD,PhDDirector, Translational Neuroscience Center atHarvard Medical School Dr. Stephen Scherer, FRSC,PhDDirector, Center for Applied Genomics atThe Hospital for Sick Children and University of Toronto

Fireside Chat with Dr. Sue Desmond-Hellmann, Bill & Melinda Gates Foundation and Dr. Penny Heaton, Bill & Melinda Gates Medical Research Institute

10:30 AM–11:45 AM Jun 7, 2018

Room 253ABC, Level 2

Sue Desmond-Hellmann, MD,MPHChief Executive Officer atBill & Melinda Gates Foundation Penny Heaton, MDChief Executive Officer atThe Bill & Melinda Gates Medical Research Institute Susan Windham-Bannister, PhDManaging Partner atBiomedical Innovation Advisors LLC